Clinical trial · Observational
Cohort of Peripheral T Cell Lymphoma
Multicenter Prospective Cohort Study of Peripheral T Cell Lymphoma
NCT02364466CI-TRIAL-00016893unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective, observational cohort study of peripheral T cell lymphoma. Purpose is to investigate the complication including febrile neutropenia in the era of pegylated G-CSF prophylaxis.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Febrile Neutropenia | — | UNRESOLVED | — |
| Lymphoma, T-Cell, Peripheral | Lymphoma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Febrile neutropenia
- timeFrame
- 2 years after the last enrollment
- description
- Incidence and severity of febrile neutropenia
Secondary outcomes (1)
- measure
- Infectious complication
- timeFrame
- 2 years after the last enrollment
- description
- incidence, severity, microbiology of infection
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: 1. Treatment naive peripheral T cell lymphoma Subtypes are as followings: Anaplastic large cell lymphoma angioimmunoblastic T cell lymphoma Peripheral T cell lymphoma-NOS Enteropathy-associated T cell lymphoma Hepatosplenic T-cell lymphoma Subcutaneous panniculitis-like T-cell lymphoma Primary cutaneous gamma-delta T-cell lymphoma Primary cutaneous CD8+ aggressive epidermotropic lymphoma 2. Scheduled to receive chemotherapy of curative intent 3. 19 years old or over 4. Expected survival is more than 6 months 5. Informed consent Exclusion Criteria: 1. Other histology than those described above * Extranodal NK/T cell lymphoma * Other than peripheral T cell lymphoma 2. Other combined malignancy 3. Previous history of chemotherapy or radiation therapy 4. No informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.